ICD-10 Code A67.1 | Intermediate lesions of pinta Symptoms, Diagnosis, Billing

Intermediate lesions of pinta are characterized by skin manifestations resulting from the infection caused by Treponema carateum. This condition is clinically significant as it can lead to severe skin deformities if left untreated. Accurate coding with ICD-10 Code A67.1 is essential for proper diagnosis, documentation, medical billing, and public health reporting, ensuring that healthcare providers can track and manage cases effectively.

What is ICD-10 Code A67.1 for Intermediate lesions of pinta?

ICD-10 Code A67.1 represents Intermediate lesions of pinta, which are skin lesions that occur in the progression of pinta, a treponemal infection. This code should be used when documenting cases that exhibit these intermediate lesions, which are critical for understanding the disease's progression and for appropriate billing and treatment planning.

ICD-10 Code A67.1 – Clinical Definition and Explanation of Intermediate lesions of pinta

Intermediate lesions of pinta are caused by the spirochete Treponema carateum, which leads to skin lesions that can progress if untreated. These lesions require medical attention to prevent further complications and deformities. Early diagnosis and treatment are crucial for effective management.

Key Clinical Features:

• Skin lesions that may appear as papules or plaques.
• Lesions can be disfiguring if not treated promptly.
• Associated with systemic symptoms such as fever or malaise.
• Epidemiologically linked to areas with poor sanitation and limited access to healthcare.

ICD-10 Code A67.1 for Intermediate lesions of pinta – SOAP Notes & Clinical Use

In SOAP notes, ICD-10 Code A67.1 is utilized to document the presence of intermediate lesions of pinta, aiding in the assessment and treatment planning. This code is relevant in both acute and chronic care settings, ensuring comprehensive patient management.

What Does ICD-10 Code A67.1 for Intermediate lesions of pinta Mean in SOAP Notes?

ICD-10 Code A67.1 connects subjective patient reports of skin lesions and objective clinical findings to a formal diagnosis. This code is vital for ensuring continuity of care, supporting accurate billing, and meeting EHR documentation standards.

Treatment Options for ICD-10 Code A67.1 – Intermediate lesions of pinta

Immediate treatment for intermediate lesions of pinta is essential to prevent progression and complications. Antibiotic therapy is the cornerstone of management.

Antibiotic Therapy:

• Benzathine penicillin G: 2.4 million units IM once.
• Doxycycline: 100 mg orally twice daily for 14 days.
• Tetracycline: 500 mg orally four times daily for 14 days.

Supportive Care:

• Topical treatments to manage skin lesions.
• Pain management as needed.
• Patient education on hygiene and skin care.

Infection Control:

• Educate patients on avoiding close contact with others until treated.
• Implement standard precautions in healthcare settings.
• Monitor for outbreaks in endemic areas.

How to Document Symptoms of Intermediate lesions of pinta (ICD-10 A67.1) in SOAP Notes

Subjective:

• Patient reports skin lesions that have changed in appearance.
• History of exposure to endemic areas.
• Complaints of itching or discomfort associated with lesions.

Objective:

• Physical examination reveals multiple papular lesions on the trunk.
• No fever or systemic signs noted.
• Skin lesions are non-tender and well-defined.

Secure, compliant, and built for trust

HIPAA-compliant and designed with privacy in mind, your patient’s data is protected. Focus on care while we safeguard your information.

Learn more

SOAP Note Guidelines for Diagnosing Intermediate lesions of pinta (ICD-10 Code A67.1)

Assessment:

• Diagnosis: Intermediate lesions of pinta, moderate severity.
• ICD-10 Code: A67.1.
• Contributing factors include poor sanitation and potential exposure.

Plan:

• Initiate benzathine penicillin G treatment.
• Educate patient on skin care and hygiene.
• Schedule follow-up in 2 weeks to assess treatment response.

Treatment & Plan Section for ICD-10 Code A67.1 – Intermediate lesions of pinta

• First-line pharmacologic treatment includes benzathine penicillin G.
• Non-pharmacologic strategies involve patient education on hygiene.
• Monitoring includes follow-up visits to assess lesion resolution.
• Consider referral to dermatology for persistent lesions.

Using ICD-10 Code A67.1 for Intermediate lesions of pinta in Billing & SOAP Note Compliance

• Select appropriate ICD-10 code based on clinical findings.
• Document symptoms clearly under Subjective (S) and Objective (O) sections.
• Ensure treatment plans align with clinical guidelines for justified billing.
• Use CPT codes that correspond to the services provided.

Related ICD-10 Codes Often Used with Intermediate lesions of pinta

• A67.0 – Pinta, early lesions
• A67.9 – Pinta, unspecified
• A69.2 – Other treponemal infections

ICD-10 Code A67.1 in Medical Billing and Insurance for Intermediate lesions of pinta

ICD-10 Code A67.1 is crucial for billing in hospital, ER, or infectious disease care settings.

Billing Notes:

• Ensure accurate documentation of the diagnosis and treatment.
• Use this code in conjunction with relevant clinical findings.
• Include key chart elements such as patient history and examination results.

Common CPT Pairings: